Is Diclegis (Doxylamine + B6) safe in pregnancy?
Common uses
Morning sickness
How Diclegis (Doxylamine + B6) works and why pregnancy changes the math
Diclegis (Doxylamine + B6) combines doxylamine (a first-generation antihistamine) with vitamin B6 (pyridoxine). The combination has the strongest evidence base of any pregnancy-specific medication on the market — it is the only drug with an FDA pregnancy A or B rating specifically for morning sickness and was developed and studied for pregnancy use.
That history is important context. The same combination was sold as Bendectin in the 1970s and 1980s before being pulled in the face of lawsuits that later studies and a Supreme Court case largely discredited. It came back to market as Diclegis (and a longer-acting version, Bonjesta) once the regulatory landscape settled. Today, ACOG and the American College of Obstetricians and Gynecologists list it as the first-line pharmacologic treatment for nausea and vomiting of pregnancy.
How Diclegis (Doxylamine + B6) risk changes by trimester
The clinical reasoning behind the verdict
FDA-approved combination of doxylamine 10mg + pyridoxine (B6) 10mg.
Dosing and what to do if symptoms keep going
Pregnancy dosing for Diclegis (Doxylamine + B6) generally follows standard adult guidance unless your provider has directed otherwise. Pregnancy changes how your body absorbs, distributes, and clears many medications, so doses that worked before may need adjustment as pregnancy progresses.
If symptoms are not responding to standard dosing of Diclegis (Doxylamine + B6), that is a conversation with your prescriber rather than a reason to escalate on your own. Pregnancy is a time when changes to medication should happen with provider involvement, both because the underlying condition may be evolving and because pregnancy-safe alternatives may be available.
Safer alternatives and how to choose between them
Generic combination (Unisom 12.5mg + B6 25mg) at bedtime, same effect.
The right alternative depends on what Diclegis (Doxylamine + B6) was being used to treat. For mild symptoms, non-medication approaches often work — saline rinses for congestion, ice for swelling, heat for muscle pain, rest for fatigue. For ongoing conditions, pregnancy-safe medications usually exist and are best identified with your provider's input.
The trap to avoid is stopping a needed medication abruptly without a replacement plan, especially for chronic conditions like hypertension, diabetes, depression, or autoimmune disease. Untreated maternal conditions usually carry pregnancy risks of their own, sometimes larger than the risks of the medication being avoided. A pregnancy-aware substitute usually beats stopping treatment.
How to bring this up with your OB, midwife, or pharmacist
The most useful conversation with a provider about Diclegis (Doxylamine + B6) starts with what you actually want to know rather than a yes-or-no question. Try one of these:
- "I take Diclegis (Doxylamine + B6) sometimes for [symptom]. Is the dose I am using fine, or would you adjust it for pregnancy?" This invites a specific answer rather than a generic "talk to your provider."
- "What is your default for [the symptom]? If your default does not work for me, what is the next step?" Knowing the escalation plan ahead of time saves time when you actually need it.
- "I have been on Diclegis (Doxylamine + B6) for [condition] since before I got pregnant. What is your read on continuing versus switching?" For chronic medications, this is the most important question, and the answer is rarely "just stop."
Pharmacists are an underused resource here. The pharmacist at your usual pharmacy can pull up your records, check interactions, and answer pregnancy-medication questions without a co-pay or an appointment. For over-the-counter products especially, a pharmacist conversation is often faster than waiting for an obstetric callback.
What recent research has been saying about Diclegis (Doxylamine + B6)
The literature on Diclegis (Doxylamine + B6) in pregnancy continues to evolve as more population-level data accumulates and as researchers control more carefully for confounding factors. The pregnancy-specific evidence base for any given medication is rarely as deep as the general adult evidence base, so cautious clinical interpretation and individualized provider conversation remain the right approach as guidance updates.
Sources and further reading
ACOG Morning Sickness 2024
Check another medication
Other pregnancy safety lookups
Or visit the Pregnancy Safety Guide to search across all 460+ lookups.